Marketable Securities, Current in USD of ORAMED PHARMACEUTICALS INC. from Q3 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
ORAMED PHARMACEUTICALS INC. quarterly Marketable Securities, Current history and change rate from Q3 2011 to Q3 2025.
  • ORAMED PHARMACEUTICALS INC. Marketable Securities, Current for the quarter ending 30 Sep 2025 was $4.96M, a 667% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $4.96M +$4.31M +667% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $1.75M -$592K -25.2% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $3.7M +$1.67M +82.4% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $3.44M +$1.63M +90.4% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 $646K 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $2.35M +$1.4M +149% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $2.03M -$241K -10.6% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $1.81M -$1.94M -51.7% 31 Dec 2023 10-Q 07 Nov 2024
Q2 2023 $943K -$5.68M -85.8% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $2.27M -$5.01M -68.8% 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $3.74M -$4M -51.7% 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 $5.23M -$617K -10.5% 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $6.63M -$585K -8.11% 30 Jun 2022 10-Q 10 Aug 2022
Q1 2022 $7.28M -$2.59M -26.3% 31 Mar 2022 10-Q 12 May 2022
Q4 2021 $7.75M -$1.08M -12.2% 31 Dec 2021 10-K 06 Mar 2023
Q3 2021 $5.85M -$3.69M -38.7% 31 Aug 2021 10-QT 30 Mar 2022
Q2 2021 $7.21M -$1.13M -13.5% 31 May 2021 10-Q 14 Jul 2021
Q1 2021 $9.87M +$4.16M +73% 28 Feb 2021 10-Q 13 Apr 2021
Q4 2020 $8.83M +$5.62M +175% 30 Nov 2020 10-Q 14 Jan 2021
Q3 2020 $9.54M +$5.84M +158% 31 Aug 2020 10-K 24 Nov 2021
Q2 2020 $8.34M +$4.11M +97.4% 31 May 2020 10-Q 07 Jul 2020
Q1 2020 $5.7M +$230K +4.2% 29 Feb 2020 10-Q 06 Apr 2020
Q4 2019 $3.21M -$1.94M -37.6% 30 Nov 2019 10-Q 09 Jan 2020
Q3 2019 $3.7M -$891K -19.4% 31 Aug 2019 10-K 24 Nov 2020
Q2 2019 $4.22M +$513K +13.8% 31 May 2019 10-Q 10 Jul 2019
Q1 2019 $5.47M +$2.25M +69.5% 28 Feb 2019 10-Q 10 Apr 2019
Q4 2018 $5.14M +$2.42M +88.9% 30 Nov 2018 10-Q 14 Jan 2019
Q3 2018 $4.59M +$1.73M +60.6% 31 Aug 2018 10-K 27 Nov 2019
Q2 2018 $3.71M +$638K +20.8% 31 May 2018 10-Q 12 Jul 2018
Q1 2018 $3.23M -$378K -10.5% 28 Feb 2018 10-Q 09 Apr 2018
Q4 2017 $2.72M -$968K -26.2% 30 Nov 2017 10-Q 11 Jan 2018
Q3 2017 $2.86M +$5K +0.18% 31 Aug 2017 10-K 28 Nov 2018
Q2 2017 $3.07M -$291K -8.65% 31 May 2017 10-Q 06 Jul 2017
Q1 2017 $3.61M +$1.53M +73.3% 28 Feb 2017 10-Q 05 Apr 2017
Q4 2016 $3.69M +$1.71M +86% 30 Nov 2016 10-Q 11 Jan 2017
Q3 2016 $2.86M +$767K +36.7% 31 Aug 2016 10-K 29 Nov 2017
Q2 2016 $3.36M +$2.61M +344% 31 May 2016 10-Q 06 Jul 2016
Q1 2016 $2.08M +$1.39M +199% 29 Feb 2016 10-Q 06 Apr 2016
Q4 2015 $1.98M +$1.3M +188% 30 Nov 2015 10-Q 13 Jan 2016
Q3 2015 $2.09M +$1.04M +99.4% 31 Aug 2015 10-K 25 Nov 2016
Q2 2015 $758K -$305K -28.7% 31 May 2015 10-Q 01 Jul 2015
Q1 2015 $695K -$769K -52.5% 28 Feb 2015 10-Q 03 Apr 2015
Q4 2014 $688K -$274K -28.5% 30 Nov 2014 10-Q 08 Jan 2015
Q3 2014 $1.05M +$91K +9.52% 31 Aug 2014 10-K 25 Nov 2015
Q2 2014 $1.06M +$260K +32.4% 31 May 2014 10-Q 14 Jul 2014
Q1 2014 $1.46M +$477K +48.3% 28 Feb 2014 10-Q 10 Apr 2014
Q4 2013 $962K -$102K -9.62% 30 Nov 2013 10-Q 14 Jan 2014
Q3 2013 $956K +$756K +377% 31 Aug 2013 10-K 14 Nov 2014
Q2 2013 $803K +$446K +125% 31 May 2013 10-Q 17 Jul 2013
Q1 2013 $987K +$646K +189% 28 Feb 2013 10-Q 11 Apr 2013
Q4 2012 $1.06M +$684K +180% 30 Nov 2012 10-Q 26 Dec 2012
Q3 2012 $200K -$184K -47.9% 31 Aug 2012 10-K 27 Nov 2013
Q2 2012 $357K 31 May 2012 10-Q 12 Jul 2012
Q1 2012 $341K 29 Feb 2012 10-Q 04 Apr 2012
Q4 2011 $380K 30 Nov 2011 10-Q 12 Jan 2012
Q3 2011 $385K 31 Aug 2011 10-K 12 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.